TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
Blood Pressure Insights in COVID-19: Watch for Drops and RAAS …
WEBSep 10, 2020 · Here, Baher Al-Abbasi, MD (University of Miami/JFK Medical Center, Atlantis, FL), and colleagues noted increased in-hospital mortality in 172 COVID-19 patients taking ACE inhibitors or ARBs compared with those not taking the drugs (33% vs 13%; P = 0.003), as well as increased likelihood of admission to the …
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Going Contrast Free in TAVI Is Safe for CKD Patients
WEBAug 20, 2024 · Promising data for noncontrast CCTA are starting to build, with the latest study showing its role in balloon-expandable valves. With the right imaging strategy—one that avoids contrast media—patients with advanced chronic kidney disease (CKD) can safely undergo TAVI without putting undue strain …
Welcome to TCTMD | tctmd.com
WEBOn behalf of CRF and TCTMD, we would like to extend a warm welcome to our community, which has developed over the past 20 years around a common goal to improve the survival and quality of life for people living with cardiovascular disease through research and education. We look forward to seeing you at our conferences and to working together to ...
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients
WEBAug 19, 2024 · Rivaroxaban’s effect on the primary efficacy endpoint was not modified by frailty status: HR 0.93 (95% CI 0.75-1.15) in the frail group versus HR 0.83 (95% CI 0.72-0.97) in the nonfrail group (P for interaction = 0.37). The most notable benefits in frail patients on rivaroxaban were reductions in limb outcomes, including the composite of …
FDA Approves Shockwave Intravascular Lithotripsy for Calcified ...
WEBFeb 16, 2021 · (UPDATED) The US Food and Drug Administration has cleared the Shockwave intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary artery plaques. The device uses a balloon to deliver sonic pressure waves that can pass through soft arterial tissue to “preferentially …
Conferences | tctmd.com
WEBMay 17, 2024 · News, slides, cases, and videos, from over 30 cardiology conferences each year.
Welcome to Your Platinum Account - TCTMD.com
WEBWe are very pleased to welcome you to your premium TCTMD account. As a premium member you have access to enhanced content including live video streams of conferences for Platinum members, and archives of live cases and presentations from numerous meetings throughout the year for Gold (and Platinum) members. If …
Skip to content